Reolysin(R) - Oncolytic virus
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F08%3A4170" target="_blank" >RIV/00216208:11130/08:4170 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/08:4170
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Reolysin(R) - Oncolytic virus
Original language description
Oncolytic viruses infect, replicate in and lyse tumor cells while sparing normal cells.
Czech name
Reolysin - onkolytický virus
Czech description
Reolysin - onkolytický virus.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA301%2F05%2F2240" target="_blank" >GA301/05/2240: Immunological mechanisms in anticancer effect of oncolytic virus</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Drugs of the Future
ISSN
0377-8282
e-ISSN
—
Volume of the periodical
33
Issue of the periodical within the volume
6
Country of publishing house
ES - SPAIN
Number of pages
7
Pages from-to
—
UT code for WoS article
000257823800003
EID of the result in the Scopus database
—